These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5059808)

  • 1. Metabolism of aniline and hexobarbital by liver homogenates of spironolactone-pretreated male rats.
    Talcott RE; Stohs SJ
    J Pharm Sci; 1972 Feb; 61(2):296-7. PubMed ID: 5059808
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of cyproterone acetate pretreatment on the in vitro metabolism of aniline, hexobarbital and 3 H-digitoxigenin.
    Talcott RE; Stohs SJ
    J Pharmacol Exp Ther; 1973 Feb; 184(2):419-23. PubMed ID: 4688178
    [No Abstract]   [Full Text] [Related]  

  • 3. Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    J Pharmacol Exp Ther; 1970 Jan; 171(1):127-34. PubMed ID: 5410930
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of starvation on the kinetics of drug oxidation by hepatic microsomal enzymes from male and female rats.
    Gram TE; Guarino AM; Schroeder DH; Davis DC; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1970 Oct; 175(1):12-21. PubMed ID: 5471443
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of adrenalectomy or alloxan diabetes on the substrate interaction with cytochrome P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Onoda K
    Biochem Pharmacol; 1971 Feb; 20(2):447-58. PubMed ID: 5150143
    [No Abstract]   [Full Text] [Related]  

  • 6. Species differences in the effect of morphine administration or adrenalectomy on the substrate interactions with cytochrome P-450 and drug oxidations by liver microsomes.
    Kato R; Onoda KI; Takanaka A
    Biochem Pharmacol; 1971 Jun; 20(6):1093-9. PubMed ID: 5118111
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of thyroid hormone on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Takahashi A
    J Biochem; 1970 Nov; 68(5):613-23. PubMed ID: 5484443
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for spironolactone as a possible inducer of liver microsomal enzymes in mice.
    Gerald MC; Feller DR
    Biochem Pharmacol; 1970 Aug; 19(8):2529-32. PubMed ID: 5520611
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cerium on drug metabolizing activity in rat liver.
    Arvela P; Kärki NT
    Experientia; 1971 Oct; 27(10):1189-90. PubMed ID: 5127875
    [No Abstract]   [Full Text] [Related]  

  • 10. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influencing of microsomal enzymes by carbon tetrachloride with and without phenobarbital pretreatment].
    Heni N
    Experientia; 1971 Mar; 27(3):293-5. PubMed ID: 4323019
    [No Abstract]   [Full Text] [Related]  

  • 12. Human liver microsomal drug metabolism.
    Darby FJ; Newnes W; Price Evans DA
    Biochem Pharmacol; 1970 Apr; 19(4):1514-7. PubMed ID: 4398013
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulation of barbiturate metabolism by spironolactone in mice.
    Gerald MC; Feller DR
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):120-4. PubMed ID: 5480132
    [No Abstract]   [Full Text] [Related]  

  • 14. Species difference in drug metabolism by liver microsomes in alloxan diabetic or fasted animals. I. The activity of drug-metabolizing enzymes and electron transport system.
    Kato R; Onoda K; Takanaka A
    Jpn J Pharmacol; 1970 Dec; 20(4):546-53. PubMed ID: 5312936
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
    Grosse W; Wade AE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):758-65. PubMed ID: 4398746
    [No Abstract]   [Full Text] [Related]  

  • 16. Species and sex differences in the substrate-induced spectral change of P-450 in relation to the activity of drug oxidation in liver microsomes.
    Kato R; Onoda K; Takayanagi M
    Jpn J Pharmacol; 1970 Mar; 20(1):157-63. PubMed ID: 5311321
    [No Abstract]   [Full Text] [Related]  

  • 17. Heredity of hexobarbital sleeping time and efficiency of drug metabolism in Wistar and Sprague-Dawley rats.
    Gut I; Becker BA
    Arch Toxicol; 1975 Sep; 34(1):61-70. PubMed ID: 1242637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phenobarbital and methylcholanthrene treatment on drug-induced difference spectrum of liver microsomes.
    Kato R; Takanaka A
    Jpn J Pharmacol; 1969 Mar; 19(1):171-3. PubMed ID: 5306217
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of spironolactone on drug metabolism by hepatic microsomes.
    Stripp B; Hamrick ME; Zampaglione NG; Gillette JR
    J Pharmacol Exp Ther; 1971 Mar; 176(3):766-71. PubMed ID: 5111461
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of dietary essential fatty acid consumption to hepatic drug hydroxylation.
    Wade AE; Wu B; Caster WO
    Pharmacology; 1972; 7(5):305-14. PubMed ID: 4644001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.